Your shopping cart is currently empty

EHMT2-IN-2 Used in the research of blood disease or cancer. EHMT2-IN-2 is a potent EHMT inhibitor, with IC50s of all <100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2.


| Description | EHMT2-IN-2 Used in the research of blood disease or cancer. EHMT2-IN-2 is a potent EHMT inhibitor, with IC50s of all <100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. |
| Targets&IC50 | EHMT2 ICW:100 nM, EHMTI PEP:100 nM, EHMT2 PEP:100 nM |
| In vitro | EHMT2-IN-2 ?is a potent EHMT inhibitor, with IC50s of all 100 nM for EEHMT1 peptide, EHMT2 peptide and cellular EHMT2. |
| Molecular Weight | 374.44 |
| Formula | C21H22N6O |
| Cas No. | 2230850-47-0 |
| Smiles | CNc1cc(C)nc(Nc2ccc(OC)c(c2)-c2[nH]c3cnccc3c2C)n1 |
| Relative Density. | 1.296 g/cm3 (Predicted) |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.